沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

已收盘 01-15 16:08:10

7.070

-0.130

-1.81%

最高7.370	最低7.010	成交量130.60万
今开7.200	昨收7.200	日振幅5.00%
总市值47.51亿	流通市值47.51亿	总股本6.72亿
成交额931.81万	换手率0.19%	流通股本6.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":7.07,"timestamp":1768464490008,"preClose":7.2,"halted":0,"volume":1306000,"delay":0,"changeRate":-0.01805555555555554,"floatShares":672000000,"shares":672000000,"eps":-0.3791121937229944,"marketStatus":"已收盘","change":-0.13,"latestTime":"01-15 16:08:10","open":7.2,"high":7.37,"low":7.01,"amount":9318115,"amplitude":0.05,"askPrice":7.07,"askSize":10000,"bidPrice":7.01,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.380586383873836,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768527000000},"marketStatusCode":5,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":7.2,"openAndCloseTimeList":[[1768440600000,1768449600000],[1768453200000,1768464000000]],"volumeRatio":1.172942,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2603395608","title":"巨子生物(02367)全资子公司收到国家药监局颁发的关于重组I型α1亚型胶原蛋白及透明质酸钠复合溶液产品的《中华人民共和国医疗器械注册证》","url":"https://stock-news.laohu8.com/highlight/detail?id=2603395608","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603395608?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:13","pubTimestamp":1768468380,"startTime":"0","endTime":"0","summary":"智通财经APP讯，巨子生物 发布公告，本公司全资子公司陕西巨子生物技术有限公司于今日收到中国国家药品监督管理局颁发的关于重组I型α1亚型胶原蛋白及透明质酸钠复合溶液产品(本产品)的《中华人民共和国医疗器械注册证》。本产品以重组胶原蛋白及透明质酸钠为主要成分，用于真皮层的注射，以改善面颊部平滑度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1583","09996","BK1207","159883","LU2488822045.USD","SG9999004311.SGD","02367","BK1222","BK1100","BK1574"],"gpt_icon":0},{"id":"2603677369","title":"爱美客：公司主营业务为Ⅲ类医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2603677369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603677369?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:24","pubTimestamp":1768465487,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问：你们有没有使用AI技术进行医疗美容？爱美客回复：尊敬的投资者您好，公司主营业务为Ⅲ类医疗器械，是Ⅲ类医疗器械的提供商。公司下游客户主要为有资质的医疗美容机构及经销商，下游客户根据法律法规及其合法资质独立对外开展医疗服务。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500024154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251","159883","09997","BK1222","BK1574","BK1583","BK1100","09996"],"gpt_icon":0},{"id":"2603162658","title":"嘉事堂：加强药品医疗器械销售配送业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2603162658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603162658?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:54","pubTimestamp":1768438449,"startTime":"0","endTime":"0","summary":"公司的互联网嘉事堂药店和互联网药店网目前也在正常运营，完全锲合目前的Ai医疗，证明了公司的远见和前瞻。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500006560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09996","002462","159883","BK1222","09997","BK1100","BK0097","BK1583","BK0028","BK0250"],"gpt_icon":0},{"id":"2603640558","title":"【ETF动向】1月14日平安医药及医疗器械创新ETF基金跌0.78%，份额增加1.06亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2603640558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603640558?lang=zh_cn&edition=full","pubTime":"2026-01-15 06:31","pubTimestamp":1768429909,"startTime":"0","endTime":"0","summary":"证券之星消息，1月14日，平安医药及医疗器械创新ETF基金（516820）跌0.78%，成交额1.41亿元。当日份额增加了1.06亿份，最新份额为46.28亿份，近20个交易日份额增加2.22亿份。当日资金净流入2620.75万元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为17.56亿元。平安医药及医疗器械创新ETF基金跟踪标的为中证医药及医疗器械创新指数，成立（2021-06-09）以来超额回报为2.07%，近一个月超额回报为0.29%，管理人为平安基金公司，基金经理为翁欣 白圭尧。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500004072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","09996","159883","09939","BK1583","BK1100","BK1515","159987","09997","BK1161","BK1222","BK1574"],"gpt_icon":0},{"id":"2603869154","title":"每日卖空追踪 | 沛嘉医疗-B 01月14日卖空量成交6.1万股，卖空比例为4.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603869154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603869154?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:30","pubTimestamp":1768379443,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间01月14日，涨3.6%，卖空量成交6.1万股，较上一交易日减少26.51%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164725a7197094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164725a7197094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2603969345","title":"国药一致：目前无代理脑机接口医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603969345?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:09","pubTimestamp":1768378147,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：脑机接口是前沿学科，市场前景广阔，公司作为国内医药及医疗器械分销龙头之一，是否与脑机接口医疗器械相关公司达成了合作或代理意向？国药一致回复：感谢您的关注！公司作为医药分销企业会争取尽可能多的合作资源，目前无代理。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400023492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0196","BK0250","BK0175","BK0028","159883","BK1100","09996","BK1222","09997","BK0010","BK0188","000028","BK1574","BK0082","BK0185"],"gpt_icon":0},{"id":"2603665925","title":"西安高新：臻泰智能再获医疗器械注册证！用“意念”进行语言认知康复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665925","media":"陕西法制网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603665925?lang=zh_cn&edition=full","pubTime":"2026-01-14 11:26","pubTimestamp":1768361160,"startTime":"0","endTime":"0","summary":"近日，西安高新区企业西安臻泰智能科技有限公司在脑机接口医疗康复领域取得重要进展。至此，臻泰智能在脑机接口康复领域相关产品注册证已增至4张，进一步巩固了其在创新康复医疗技术方面的领先地位。臻泰智能此次获批的“言语与认知功能康复训练评估系统”，能够帮助脑卒中及其他脑损伤导致的言语、记忆等认知障碍患者进行康复。目前，臻泰智能的全系列脑机康复产品已进入全国超300家医院，累计服务患者约十万人次。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-01-14/doc-inhhfvyz4204787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","09997","09996","BK1574","BK1222","BK1100","BK1583"],"gpt_icon":0},{"id":"2603771315","title":"港股异动 | 堃博医疗-B(02216)涨近10% BroncTarget®系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2603771315","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603771315?lang=zh_cn&edition=full","pubTime":"2026-01-13 13:49","pubTimestamp":1768283357,"startTime":"0","endTime":"0","summary":"消息面上，1月12日晚，堃博医疗发布公告称，旗下BroncTarget肺部靶向去神经射频消融系统正式进入中国国家药品监督管理局的创新医疗器械特别审查程序，标志着该产品在核心技术原创性、临床价值显著性等方面获得国家药监部门的认可。目前，BroncTarget系统的确证性临床试验正在有序开展中，全国28家医院正同步推进受试者招募。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1583","159883","BK1574","09997","BK1222","BK1100","02216"],"gpt_icon":0},{"id":"2602517496","title":"堃博医疗-B(02216)：BroncTarget®肺部靶向去神经射频消融系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517496","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602517496?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:58","pubTimestamp":1768222714,"startTime":"0","endTime":"0","summary":"智通财经APP讯，堃博医疗-B 发布公告，旗下BroncTarget肺部靶向去神经射频消融系统正式进入中国国家药品监督管理局的创新医疗器械特别审查程序，标志着该产品在核心技术原创性、临床价值显著性等方面获得国家药监部门的认可。目前，BroncTarget系统的确证性临床试验正在有序开展中，全国28家医院正同步推进受试者招募。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","159883","02216","BK1583","BK1100","09997","BK1222","BK1574"],"gpt_icon":0},{"id":"2602971205","title":"透景生命(300642.SZ)：骨髓增生异常综合征染色体及基因异常检测试剂盒(荧光原位杂交法)医疗器械注册获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2602971205","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602971205?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:47","pubTimestamp":1768207625,"startTime":"0","endTime":"0","summary":"40%-70%的原发性骨髓增生异常综合征患者在初诊时便存在染色体异常。应用骨髓增生异常综合征组套探针进行荧光原位杂交检测，可提高部分患者细胞遗传学异常检出率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1222","BK1583","BK0046","09996","BK0042","BK1100","159883","300642","BK1574","BK0239"],"gpt_icon":0},{"id":"2602590218","title":"每日卖空追踪 | 沛嘉医疗-B 01月12日卖空量成交10.7万股，卖空比例为4.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602590218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602590218?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206641,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间01月12日，涨5.3%，卖空量成交10.7万股，较上一交易日增加98.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165318a710cdde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165318a710cdde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1100","09996","BK1574"],"gpt_icon":0},{"id":"2602506564","title":"国泰海通证券：维持威高股份(01066)“增持”评级 医疗器械旗舰平台定位进一步明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2602506564","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602506564?lang=zh_cn&edition=full","pubTime":"2026-01-12 09:53","pubTimestamp":1768182795,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国泰海通证券发布研报称，维持威高股份“增持”评级，给予目标价7.84港元，威高血净拟发行股份收购威高普瑞全部股权，通过此次整合，威高股份将成为威高血净的控股股东，进一步明确其作为集团旗下医疗器械旗舰平台的定位。公司医疗器械旗舰平台定位进一步明确交易后，公司将持有威高血净52.10%股权，成为其控股股东并合并财务报表。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01066","09996","02611","09997","161027","159883"],"gpt_icon":0},{"id":"2602541216","title":"医疗器械2026年度策略：把握出海陡峭曲线 卡位AI医疗商业化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2602541216","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602541216?lang=zh_cn&edition=full","pubTime":"2026-01-12 00:00","pubTimestamp":1768147200,"startTime":"0","endTime":"0","summary":"AI应用、脑机接口：自上而下，把握产业大周期下商业化开启阶段十五五”规划开年，预计后续开年财政也将会释放更积极信号，重视超跌底部AI医疗应用机会。建议关注组合战略组合微创医疗微电生理联影医疗迈瑞医疗弹性组合瑞迈特天智航微创机器人康众医疗润达医疗风险提示：海外商业化不及预期的风险，临床及获批进度不及预期的风险，市场竞争加剧风险，集采政策不及预期的风险，新技术商业化不及预期的风险","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112205142a4babe94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112205142a4babe94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1222","02252","09996","BK1100","BK1617","BK1574","09997"],"gpt_icon":0},{"id":"2602038551","title":"医疗器械行业周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2602038551","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602038551?lang=zh_cn&edition=full","pubTime":"2026-01-11 00:00","pubTimestamp":1768060800,"startTime":"0","endTime":"0","summary":"建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111165652a70d4376&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111165652a70d4376&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01302","BK1583","BK1600","BK1574","BK1100","09997","BK1222","09996"],"gpt_icon":0},{"id":"2602372320","title":"美康生物（300439）披露取得两项医疗器械注册证，1月9日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602372320","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602372320?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:49","pubTimestamp":1767970151,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，美康生物报收于10.19元，较前一交易日上涨0.49%，最新总市值为39.16亿元。该股当日开盘10.13元，最高10.2元，最低10.07元，成交额达4587.65万元，换手率为1.55%。公司近日发布公告称，美康生物科技股份有限公司近日取得国家药品监督管理局和浙江省药品监督管理局颁发的两项医疗器械注册证，分别为乙型肝炎病毒e抗体测定试剂盒和高尔基体蛋白73检测试剂盒，有效期均为2025年12月至2030年12月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09996","09997","BK0046","BK1583","159883","300439","BK1222","BK0042","BK0239","BK1100"],"gpt_icon":0},{"id":"2602767523","title":"毛利率超75%！又一国产械企冲击IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2602767523","media":"医疗器械经销商...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602767523?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:54","pubTimestamp":1767963240,"startTime":"0","endTime":"0","summary":"它不仅列出了全球75款和国内315款创新医疗器械产品，还从政策支持、市场前景、核心技术、临床应用、竞争格局、厂家实力等多个维度进行了全方位评估。打破信息壁垒、减少信息不对称，帮助医疗器械经销商，深度且全面地了解目前市面上的创新医疗器械产品。从落地推行来看，创新医疗器械DRG除外支付，进院绿色通道等影响着进院。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-01-09/doc-inhftipq1420607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1583","BK1100","09996","09997","BK1222"],"gpt_icon":0},{"id":"2602375578","title":"新股消息 | 东山精密(002384.SZ)拟港股上市 中国证监会要求补充说明医疗器械生产开展情况等","url":"https://stock-news.laohu8.com/highlight/detail?id=2602375578","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602375578?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:07","pubTimestamp":1767960437,"startTime":"0","endTime":"0","summary":"中国证监会国际司共对10家企业出具补充材料要求，其中，要求东山精密补充说明医疗器械生产开展情况等事项。证监会请东山精密补充说明以下事项，请律师核查并出具明确的法律意见：一、请补充说明你公司医疗器械生产、佣金代理、信息技术及社会经济咨询服务、太阳能产品系统的生产安装销售、太阳能工业技术研究咨询服务等业务开展情况，是否取得必要的资质许可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","159883","BK0109","BK0171","09996","BK0152","002384","BK0102","BK0076","BK1100","BK0141","BK0196","BK1222","BK0214","BK1583","09997"],"gpt_icon":0},{"id":"2602329468","title":"美康生物(300439.SZ)取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2602329468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602329468?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:33","pubTimestamp":1767951193,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美康生物(300439.SZ)公告，公司近日取得了由国家药品监督管理局、浙江省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》，包括：乙型肝炎病毒e抗体测定试剂盒(化学发光微粒子免疫检测法)、高尔基体蛋白73检测试剂盒(化学发光微粒子免疫检测法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","300439","09997","BK0239","BK1222","BK1583","BK1100","BK1574","BK0042","BK0046","159883"],"gpt_icon":0},{"id":"2602032827","title":"正海生物(300653.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2602032827","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602032827?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:59","pubTimestamp":1767945545,"startTime":"0","endTime":"0","summary":"智通财经APP讯，正海生物(300653.SZ)公告，公司近日取得由国家药品监督管理局下发的《医疗器械注册证》，产品名称为：钙硅生物陶瓷口腔骨修复材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1574","BK1100","BK0251","BK1583","BK0046","300653","159883","BK1222","09996"],"gpt_icon":0},{"id":"2602401993","title":"河北省衡水市市场监管局桃城区分局开展药品和医疗器械经营使用环节质量安全专项检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2602401993","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602401993?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:11","pubTimestamp":1767942660,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 为进一步规范辖区药械使用环节监管秩序，切实保障人民群众用药用械安全有效，河北省衡水市市场监督管理局桃城区分局扎实开展药械使用单位质量安全监管工作。衡水市市场监督管理局桃城区分局将进一步加大辖区药械使用单位监管力度，对重点检查事项及存在问题的单位组织开展“回头看”，确保监管工作出实招、用实劲、见实效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-01-09/doc-inhfswxr5898150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1100","09997","159883","09996","BK1222","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0.0942},{"period":"1month","weight":0.1803},{"period":"3month","weight":0.1163},{"period":"6month","weight":-0.1166},{"period":"1year","weight":0.9251},{"period":"ytd","weight":0.198}],"compareEarnings":[{"period":"1week","weight":0.0204},{"period":"1month","weight":0.0535},{"period":"3month","weight":0.0429},{"period":"6month","weight":0.0876},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.0534}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.040476},{"month":2,"riseRate":0.6,"avgChangeRate":0.039503},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}